Synthesis of a novel 89 Zr-labeled HER2 affibody and its application study in tumor PET imaging
ConclusionThe novel HER2 affibody for PET imaging was easily prepared with satisfactory labeling yield and radiochemical purity. [89Zr]Zr-DFO-MAL-Cys-MZHER2 is a potential candidate for detecting HER2 expression. It may play specific roles in clinical cancer theranostics.
Source: EJNMMI Research - Category: Radiology Source Type: research
More News: Cancer | Cancer & Oncology | HER2 | Ovarian Cancer | Ovaries | Radiology | Study | Urology & Nephrology